Soothing Lip Mask Base

1. INCI et CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Rôle dans la formule

Butyrospermum Parkii Butter is listed as a butter in this development reference. The recorded formula also lists Caprylic/Capric Triglyceride and Squalane. Review the contribution to body and application feel in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• In this reference, the component allocation is 22% w/w.

Incorporate melted Butyrospermum Parkii Butter in the oil phase and maintain shear during cooling to reduce grain formation.

4. Sources réglementaires et conformité mondiale

• Read this as formulation guidance for development; it does not authorize a particular grade or finished formula; No authorization for the final cosmetic is implied.

5. Sécurité et évaluation des risques

The concentration shown is guidance for cosmetic formulation; the note establishes neither drug approval nor OTC-monograph status and patch and stability testing remain part of finished-product review.

6. Stabilité et conditionnement

Hold the bulk material in a sealed, cool place shielded from light; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic concept for Butyrospermum Parkii Butter in this entry centers on shea cushion.

• This reference provides no basis for claims of drug activity, a clinical cure, or an undocumented product certification.
• The ingredient note for Butyrospermum Parkii Butter does not demonstrate skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI et CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Rôle dans la formule

Caprylic/Capric Triglyceride is listed as an emollient in the formulation reference. The recorded formula also lists Butyrospermum Parkii Butter and Squalane. Review spreading, slip and the finish of the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The listed guide allocation for this component is 20% w/w.

The guide places Caprylic/Capric Triglyceride in the oil phase.

4. Sources réglementaires et conformité mondiale

• Treat this information as a development reference; it establishes no approval for the raw material or the final product; The finished cosmetic is outside the approval represented by this note.

5. Sécurité et évaluation des risques

Use the stated level as reference guidance for cosmetic formulation; no drug approval or OTC-monograph status follows from this guide so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Use cool, sealed storage away from strong light for the bulk; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; use batch testing to verify stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic role of Caprylic/Capric Triglyceride is presented as light-triglyceride.

• This formulation entry does not support claims of drug activity, a clinical cure, or an undocumented product certification.
• This reference for Caprylic/Capric Triglyceride is not evidence for whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane is listed as an emollient in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Caprylic/Capric Triglyceride. Review spreading, slip and the finish of the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The component's reference allocation is recorded at 16% w/w.

Add Squalane to the oil phase; no high-shear wax step is required.

4. Sources réglementaires et conformité mondiale

• The record provides guidance for development; it does not verify or approve the material grade or completed formula; This development information is not a product approval.

5. Sécurité et évaluation des risques

This entry provides guidance for cosmetic use only; it is not evidence of drug approval or OTC authorization and the completed formula still requires stability and patch testing.

6. Stabilité et conditionnement

Store the bulk in a closed container in a cool, shaded place; consider an airless or pump format when oxidation sensitivity warrants it; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Squalane in a direction centered on a light-emollient role.

• This reference does not establish drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The Squalane entry does not confirm whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.